Sign in|Join free
Nanjing JiuSiNuo Biopharmaceutical Technology Co., Ltd

Nanjing JiuSiNuo Biopharmaceutical Technology Co., Ltd

Product Catalog
Current Location: HOME >> Product
Product Categories
Country: China
Tel:
Mobile: 18851976882
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-, (5α,6β)-, 1,2-benzenedicarboxylate (1:1) C29H34N2O7 152657-10-8 Details
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide C28H32N2O5 152658-36-1 Details
lubiprostone C20H32F2O5 333963-40-9 Details
Choline Fenofibrate C22H28ClNO5 856676-23-8 Details
Trifluridine C10H11F3N2O5 70-00-8 Details
Ceritinib C28H36ClN5O3S 1032900-25-6 Details
NA Details
tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate C16H29N3O7 1210348-34-7 Details
Naloxone hydrochloride C19H22ClNO4 357-08-4 Details
NA Details
Levalbuterol hydrochloride C13H22ClNO3 50293-90-8 Details
Riociguat C20H19FN8O2 625115-55-1 Details
Revefenacin C35H43N5O4 864750-70-9 Details
162819-83-2 C28H34N2O3 162819-83-2 Details
NA Details
NA Details
3-Furaldehyde C5H4O2 498-60-2 Details
(5α,6α)-17-(CyclopropylMethyl)-4,5-epoxy-6-(MethylaMino)-Morphinan-3,14-diol C21H28N2O3 102919-85-7 Details
2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(2-furanyl)-N-methyl-, (E)- (9CI) C28H32N2O5 152658-02-1 Details
Naltrexone EP Impurity H C20H25NO4 503090-99-1 Details
(1S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1]octan-7-one C7H9BrO2 139893-81-5 Details
NA Details
(5α,6β)-17-(CyclopropylMethyl)-4,5-epoxy-6-(MethylaMino)-Morphinan-3,14-diol C21H28N2O3 102869-99-8 Details
7,8-Dihydro-14-hydroxy- normorphinone C16H17NO4 33522-95-1 Details
(1S,3R,4R)-3-amino-4-hydroxy-N,N-dimethylcyclohexanecarboxamide C9H18N2O2 929693-36-7 Details
Cyclohexanecarboxamide, 4-bromo-3-hydroxy-N,N-dimethyl-, (1S,3S,4S)- C9H16BrNO2 1629245-79-9 Details
NA Details
ZVPVPYWMFMUFEZ-UHFFFAOYSA-N C35H42N4O5 909800-36-8 Details
NA Details
6-BETA-NALTREXOL HCL C20H25NO4 49625-89-0 Details
2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-10-oxomorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (2E)- C28H30N2O6 1054312-73-0 Details
Platinum(2+), diamminediaqua-, (SP-4-2)-, dinitrate H6N3O5Pt+ 52241-26-6 Details
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate C15H28N2O6S 929693-31-2 Details
Deferasirox Isopropyl Ester C24H21N3O4 1266741-29-0 Details
1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-α-D-erythro-pentofuranosyl)-3,6-dihydro- C8H14N4O4 114522-17-7 Details
DescyclopropylMethyl Nalfurafine C24H26N2O5 163713-06-2 Details
10α-Hydroxy-nalfurafine C28H32N2O6 1054312-75-2 Details
Platinum, diamminechloro(hydroxyacetato-O1)-, (SP-4-3)- (9CI) C2H7ClN2O3Pt 157176-10-8 Details
Platinum, diamminedihydroxy[2-(hydroxy-κO)acetato(2-)-κO]-, (OC-6-44)- C2H6N2O5Pt 103436-60-8 Details
NA Details
Naltrexone 3-Methyl Ether C21H25NO4 16617-07-5 Details
Disalicylimide C14H11NO4 1972-71-0 Details
Tafluprost C25H34F2O5 209860-87-7 Details
Deferasirox Impurity 8 C21H15N3O4 201530-78-1 Details
Carbamic acid, N-[[[(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]amino]sulfonyl]-, 1,1-dimethylethyl ester C14H27N3O6S 1629245-68-6 Details
Nedaplatin C2H6N2O3Pt 95734-82-0 Details
NA Details
NA Details
4H-1,3-Benzoxazin-4-one, 2-(5-chloro-2-hydroxyphenyl)- C14H8ClNO3 24798-50-3 Details
NA Details
Deferasirox Methyl Ester C22H17N3O4 1266741-05-2 Details
5-Aza-2'-deoxycytidine C8H12N4O4 2353-33-5 Details
Naltrexone hydrochloride C20H24ClNO4 16676-29-2 Details
Cyclohexanecarboxamide, 3-amino-4-hydroxy-N,N-dimethyl-, hydrobromide (1:1), (1S,3R,4R)- C9H18N2O2.BrH 2964483-51-8 Details
NA Details
Deferasirox C21H15N3O4 201530-41-8 Details
NA Details
3-(2-Furyl)acrylic acid C7H6O3 539-47-9 Details
4H-1,3-Benzoxazin-4-one, 6-chloro-2-(2-hydroxyphenyl)- C14H8ClNO3 26276-85-7 Details
NA Details
Platinum (II), diammineoxalato-, cis- C2H4N2O4Pt 41349-15-9 Details
azanide: dihydroxy-oxo-azanium: platinum(+4) cation: dihydroxide H8N5O5Pt2+ 62048-58-2 Details
Palonosetron Hydrochloride C19H25ClN2O 135729-62-3 Details
tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate C14H27N3O3 365998-36-3 Details
Salbutamol C13H21NO3 34391-04-3 Details
Cabozantinib impurity 26 C28H25ClFN3O5 2840522-80-5 Details
Benzoic acid, 4-[5-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]- C21H14ClN3O4 1620154-59-7 Details
PeMetrexed EP IMpurity C C40H40N10O13 1802552-16-4 Details
1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- C39H34N4O8 2439164-91-5 Details
carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester C14H26N2O4 929693-30-1 Details
(1S,3S,6R)-N,N-dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide C9H15NO2 929693-35-6 Details
PALONOSETRON HCL C19H24N2O 135729-75-8 Details
PeMetrexed EP IMpurity D C25H28N6O9 144051-68-3 Details
Pemetrexed Disodium C20H22N5NaO6 150399-23-8 Details
Ilaprazole C19H18N4O2S 172152-36-2 Details
PeMetrexed EP IMpurity A C21H23N5O6 869791-42-4 Details
trans-Dichlorodiamineplatinum(II) Cl2H4N2Pt 14913-33-8 Details
EsoMeprazole related substance H431/41 C16H15N3O4 1227380-90-6 Details
Edoxaban Impurity 16 C14H25N5O3 480450-69-9 Details
Esomeprazole C17H19N3O3S 119141-88-7 Details
2-Pyridinecarboxylic acid, 1,4-dihydro-5-methyl-4-oxo-1-[6-(1H-pyrrol-1-yl)-1H-benzimidazol-2-yl]- C18H14N4O3 1508282-87-8 Details
Cabozantinib C28H24FN3O5 849217-68-1 Details
SalbutaMon Hydrochloride C13H20ClNO3 41489-89-8 Details
Edoxaban (TsOH salt) C31H38ClN7O7S2 480449-71-6 Details
PeMetrexed EP IMpurity E C20H21N5O6 182009-04-7 Details
Deferasirox Ethyl Ester C23H19N3O4 201530-79-2 Details
PeMetrexed EP IMpurity B C40H40N10O13 1802552-04-0 Details
evocalcet C24H26N2O2 870964-67-3 Details
XGZZHZMWIXFATA-VQNNHZPYSA-N C28H32N2O5 163712-68-3 Details
Product Total： Product Page：
1